BioSpace News Archive

Truth Initiative and Kaiser Permanente, in collaboration with the American Heart Association and EVERFI, have been named the winners of a 2021 Silver Halo Award in the Best Health Initiative Category for their work on Vaping: Know the truth, the national vaping prevention curriculum and quitting resource for students

The OTCQB, operated by OTC Markets Group Inc., is designed for early-stage and developing U.S. and international companies.

Doximity, Inc. today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its Class A common stock.

Guardant Health, Inc. (Nasdaq: GH) announces that the U.S. Food and Drug Administration (FDA) has approved the Guardant360® CDx test as the first and only liquid biopsy companion diagnostic for tumor mutation profiling, or comprehensive genomic profiling, to identify patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who harbor the KRAS G12C mutation and may benefit from LUMAKRAS™ (sotorasib),

BridgeBio Pharma, Inc. (Nasdaq: BBIO), through its affiliate QED Therapeutics, Inc., and Helsinn Group today announced that the US Food and Drug Administration (FDA) has approved TRUSELTIQ™ (infigratinib) under the accelerated approval program for the treatment of patients with previously-treated locally advanced or metastatic cholangiocarcinoma (CCA) harboring an FGFR2 fusion or rearrangement

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the Conditional Marketing Authorization (CMA) for COMIRNATY® in the European Union (EU) has been expanded to include individuals 12 to 15 years of age.

Akero Therapeutics, Inc., a cardio-metabolic biotechnology company developing transformational treatments for non-alcoholic steatohepatitis, announced that members of the management team will present at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 2:30 p.m..

According to the report, the global adrenocorticotropic hormone (ACTH) market was valued at US$ 1.47 Bn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027.

The vendor landscape in the global dental prosthetics market demonstrates a relatively consolidated structure, states a new report by Transparency Market Research (TMR).

Transparency Market Research has published a new report titled, “Global Periodontal Therapeutics Market”. According to the report, the global periodontal therapeutics market was valued at US$ 537.0 Mn in 2018 and is projected to expand at a CAGR of 8.8% from 2019 to 2027.